NATRIXAM

This brand name is authorized in Estonia, France, Hong Kong, Croatia, Lithuania, Malta, Nigeria, Netherlands, Romania, Singapore, Tunisia, Turkey

Active ingredients

The drug NATRIXAM contains a combination of these active pharmaceutical ingredients (APIs):

1 Amlodipine UNII 864V2Q084H - AMLODIPINE BESYLATE

Amlodipine is a calcium ion influx inhibitor of the dihydropyridine group (slow channel blocker or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle. Read about Amlodipine

2 Indapamide UNII F089I0511L - INDAPAMIDE

Indapamide is a sulfonamide derivative with an indole ring, pharmacologically related to thiazide diuretics, which acts by inhibiting the reabsorption of sodium in the cortical dilution segment. It increases the urinary excretion of sodium and chlorides and, to a lesser extent, the excretion of potassium and magnesium, thereby increasing urine output and having an antihypertensive action. Read about Indapamide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
NATRIXAM Modified-release tablet	Web Search	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C08GA02		C Cardiovascular system → C08 Calcium channel blockers → C08G Calcium channel blockers and diuretics → C08GA Calcium channel blockers and diuretics
Discover more medicines within C08GA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1588169, 1588170, 1588181, 1588192, 1588204, 1588215, 1588226, 1588237, 1588248, 1588259, 1588260, 1588271
Country: FR	Base de données publique des médicaments	Identifier(s): 66660014, 67290596
Country: HK	Department of Health Drug Office	Identifier(s): 65206, 65207
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-053397374, HR-H-921621992
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1066883, 1066884, 1066885, 1066886, 1071906, 1071907, 1071908, 1071909, 1071910, 1071911, 1071912, 1071913, 1091876, 1091877, 1091878, 1091879
Country: MT	Medicines Authority	Identifier(s): MA066/02101, MA066/02102
Country: NG	Registered Drug Product Database	Identifier(s): B4-4152, B4-4153
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 113492, 113506
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W60529001, W60529002, W60529003, W60529004, W60529005, W60529006, W60530001, W60530002, W60530003, W60530004, W60530005, W60530006
Country: SG	Health Sciences Authority	Identifier(s): 14901P, 14902P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 6353181, 6353182
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699552030102, 8699552030119